Dolinnov
1 known investors
Find your way into Dolinnov
Dolinnov is a pharmaceutical company developing next-generation painkillers based on a Precision Pump Modulator that targets the ion pump driving neuronal hyperexcitability rather than blocking ion channels. It focuses on treatments for extreme chronic pain and other serious diseases with significant unmet medical needs.
Founders & leadership
GS
Grégoire SerrainFounderFounder and CEO of Dolinnov, a pharmaceutical company developing next-generation painkillers for extreme chronic pain and other serious diseases. He works on moving preclinical assets into clinical development and building partnerships in the pharmaceutical industry.
Investors · 1
Frequently asked questions
- What does Dolinnov do?
- Dolinnov is a pharmaceutical company developing next-generation painkillers based on a Precision Pump Modulator that targets the ion pump driving neuronal hyperexcitability rather than blocking ion channels. It focuses on treatments for extreme chronic pain and other serious diseases with significant unmet medical needs.
- Who founded Dolinnov?
- Dolinnov was founded by Grégoire Serra.
- Who are Dolinnov's investors?
- Dolinnov's investors include Agoranov.